Safety, Tolerability, Distribution & Dose Effect of Neoadjuvant Transarterial Chemoembolization With Doxorubicin in Prostate Cancer Patients Before Radical Prostatectomy

Clinical trial NCT04423913 · TERMINATED

Trial details

NCT number: NCT04423913
Sponsor: Centre Hospitalier Universitaire de Nīmes
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2022-05-04
Primary completion: 2022-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.